>

Cory berkland - Cory Berkland: Resources, Writing - review & e

Cory Berkland 1 , Kyekyoon Kim, Daniel W Pack. Affiliation 1 Department of Chemical and Biomolecular

Settimio Pacelli, a, 1 Sayantani Basu, a, 1 Jonathan Whitlow, a Aparna R. Chakravarti, a Francisca Acosta, a Arushi Varshney, b Saman Modaresi, a Cory Berkland, a, c and Arghya Paul a Settimio PacelliNabil Alhakamy • Cory Berkland • Jin Chen • Dana Brantley-Sieders • Nikki Cheng Received: 4 December 2014/Accepted: 24 February 2015/Published online: 6 March 2015 Springer Science+Business Media New York 2015 Abstract Luminal A and B breast cancers are the most prevalent forms of breast cancer diagnosed in women.Charles Allen Thomas Professor of Chemistry, Chair and Professor of Chemistry. John . HeemstraWhat We Do. Our lab works at the interface of medicine and engineering with an emphasis on precisely controlling the physical and chemical properties of particles and biomaterials. The lab environment fosters multidisciplinary interaction between graduate and undergraduate researchers from the departments of Chemical and Petroleum Engineering ...Cory Berkland Laird Forrest Michael Hageman Jeff Krise Sue Lunte Russ Middaugh Christian Schöneich Teruna Siahaan John Stobaugh Thomas Tolbert David Volkin Michael Wang Undergraduate Research Program ...A new pH-sensitive triblock copolymer, polyethylene glycol-block-poly(2-dimethylaminoethyl methacrylate)-block-poly(2-diisopropylaminoethyl methacrylate) (PEG-PDMA-PDPA), was synthesized via atom transfer radical polymerization (ATRP).The potential of this polymer for siRNA delivery was assessed. This triblock copolymer formed nanocapsules with high siRNA encapsulation efficiency that ...J. Daniel Griffin, Martin A. Leon, Jean R. Salash, Michael Shao, Brittany L. Hartwell, Chad J. Pickens, Joshua O. Sestak, Cory Berkland. Acute B-Cell Inhibition by Soluble Antigen Arrays Is Valency-Dependent and Predicts Immunomodulation in Splenocytes. Biomacromolecules 2019, 20 (5) , 2115-2122.Intercellular cell-adhesion molecule-1 (ICAM-1) is up-regulated on the vascular endothelium in response to pro-inflammatory cytokines produced in the synovial cavity of patients with Rheumatoid Arthritis.Mar 21, 2018 · Chad J Pickens 1 , Stephanie N Johnson 1 , Melissa M Pressnall 1 , Martin A Leon 2 , Cory J Berkland 1 2 3 Affiliations 1 Department of Pharmaceutical Chemistry , University of Kansas , 2095 Constant Avenue , Lawrence , Kansas 66047 , United States. Calcium-crosslinked LABL-TAT complexes effectively target gene delivery to ICAM-1 expressing cells Supang Khondee1, Abdulgader Baoum1, Teruna J. Siahaan1, and Cory Berkland1,2,* 1Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS 66047 2Department of Chemical and Petroleum Engineering, The University of Kansas, Lawrence, KSJan 26, 2023 · Berkland is currently serving as the commander, 354th Fighter Wing, Pacific Air Forces, Eielson Air Force Base, Alaska. Air Force Col. Amy S. Bumgarner for appointment to the grade of brigadier ... Charles Allen Thomas Professor of Chemistry, Chair and Professor of Chemistry. John . HeemstraBudesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution Nashwa El-Gendy1, Eric M. Gorman1, Eric J. Munson1, and Cory Berkland1,2,* 1Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS 66047 2Department of Chemical and Petroleum Engineering, The University of Kansas, Lawrence, KS 66047 Abstract ...Acute B-Cell Inhibition by Soluble Antigen Arrays is Valency-Dependent and Predicts Immunomodulation in Splenocytes J. Daniel Griffin1, Martin A. Leon2, Jean R. Salash3, Michael Shao4, Brittany L. Hartwell1, Chad J. Pickens3, Joshua O. Sestak3, Cory Berkland1,3,4 1Bioengineering Graduate Program, University of Kansas, Lawrence, KS 2Department of Chemistry, University of Kansas, Lawrence, KSC. Berkland, K. Kim, and D.W. Pack (2004) Controlling double-walled microcapsule shell thickness offers modulated piroxicam release Journal of Biomedical Materials Research 70A(4):576-584 C. Berkland, K. Kim, and D.W. Pack (2004) Uniform double-walled polymer microspheres of controllable shell thickness Journal of Controlled Release, 96(1):101-111 Qingting Hu, 1 Megan Myers, 1 Wei Fang, 1 Min Yao, 1 Gage Brummer, 1 Justin Hawj, 1 Curtis Smart, 1 Cory Berkland, 2 and Nikki Cheng 1, 3, * Qingting Hu 1 Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USAChad J Pickens 1 , Stephanie N Johnson 1 , Melissa M Pressnall 1 , Martin A Leon 2 , Cory J Berkland 1 2 3 Affiliations 1 Department of Pharmaceutical Chemistry , University of Kansas , 2095 Constant Avenue , Lawrence , Kansas 66047 , United States.Cory Berkland might not be the first person you'd guess would help to create what has become a multimillion-dollar company. The distinguished professor, appointed in the departments of Pharmaceutical Chemistry and Chemical & Petroleum Engineering at the University of Kansas, grew up on a pig farm in Iowa, studied chemical engineering at the undergraduate and […]Qun Wang, Jinxi Wang, Qinghua Lu, Michael S. Detamoreand Cory Berkland. Injectable PLGA based Colloidal Gels for Zero-order Dexamethasone Release in Cranial Defects. Biomaterials 2010, 31(18): 4980-4986. 17. Qun Wang, Xianwen Hu, Yumin Du and John F. Kennedy. Alginate/Starch Blend Fibers and Their Properties for Drug Controlled Release.Feb 14, 2022 · The company’s lead candidate, BBI-001, is an iron chelator for the treatment of hereditary hemochromatosis. Bond joins the St. Louis ecosystem after licensing technology originally developed at the University of Kansas. Bond was founded by St. Louisan and serial entrepreneur Cory Berkland, PhD. Cory Berkland, Ph.D. Abstract Basic principles have emerged for oral and intravenous drug design, but fewer efforts have ... Berkland is a co-founder of Orbis Biosciences (purchased by Adare Pharmaceuticals), Savara Pharmaceuticals (NASDAQ: SVRA), Bond Biosciences, and Orion BioScience. Title: Microsoft Word - Cory Berkland Seminar Announcement ...By Akihisa Nonoyama, Ph.D., Nathan Dormer, Ph.D., and Cory Berkland, Ph.D., Adare Pharma Solutions Quetiapine is an antipsychotic drug used for the treatment of schizophrenia, bipolar disorder and depression and is currently marketed as a QD tablet. An alternate presentation of the drug in the form of controlled release microspheres would ...Aug 2, 2016 · Fang WB, Yao M, Jokar I, Alhakamy N, Berkland C, Chen J, Brantley-Sieders D, Cheng N. The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells. Breast Cancer Res Treat. Cory Berkland & Daniel W. Pack. Department of Electrical and Computer Engineering, University of Illinois, Urbana, Illinois, 61801. Kyekyoon (Kevin) Kim. Authors. Cory Berkland. View author publications. You can also search for this author in PubMed Google ...The present study aims to develop a stable polymeric micellar formulation of curcumin (CM) with improved solubility and stability, and that is suitable for clinical applications in leukemia patients. CM-loaded polymeric micelles (CM-micelles) were prepared using poloxamers. The chemical structure of …Emily C. Beck, Brooke L. Lohman, Daniel B. Tabakh, Sarah L. Kieweg, Stevin H. Gehrke, Cory J. Berkland, Michael S. Detamore. Enabling Surgical Placement of Hydrogels Through Achieving Paste-Like Rheological Behavior in Hydrogel Precursor Solutions. Annals of Biomedical Engineering 2015, 43 (10) , 2569-2576.Cory Berkland, CEO [email protected]. Release Summary. Phase Ia/b will assess the safety of BBI-001 and test the ability of BBI-001 to prevent iron uptake from food. Contacts.A method of forming particles comprises accelerating a stream comprising a liquid; and vibrating the stream, to form particles. The particle may have a diameter that is smaller than the diameter of the nozzle used to form the stream, allowing for the formation of micro- and nano-sized particle.Cory Berkland Solon E. Summerfield Distinguished Professor Department of Pharmaceutical Chemistry Contact Info [email protected] 785-864-1455 Multidisciplinary Research Building, Room 320E 2030 Becker Drive Lawrence, KS 66047 Personal Links Cory Berkland Research Education — Ph.D. in Chemical and Biomolecular Engineering, University of IlliniosCory Berkland, PhD. WIZARD FEATURES. © 2023 DeKosky Lab.Cory BERKLAND | Cited by 10,026 | of University of Kansas, Kansas (KU) | Read 243 publications | Contact Cory BERKLANDNabil A Alhakamy 1 , David T Curiel 2 , Cory J Berkland 3 Affiliations 1 Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia; ... University of Kansas, Lawrence, KS 66047, USA. Electronic address: [email protected]. PMID: 33781953 DOI: 10.1016/j.drudis.2021.03.021 AbstractSupang Khondee, Tatyana Yakovleva, Cory Berkland. First published: 04 August 2010. https://doi.org/10.1002/app.32460. Citations: 2. Read the full text. PDF. …30‏/03‏/2016 ... Cory Berkland; Dr. S. Connor Dennis; Dr. Michael Detamore. References ... Cory J Berkland. Google. S Connor Dennis · Jon Whitlow · Michael S ...Cory Berkland joins the faculty Nov. 1 from The University of Kansas, where he is the Solon E. Summerfield Distinguished Professor of Chemical and Petroleum Engineering and Pharmaceutical Chemistry. He has been on the faculty since 2003. In addition, he is the cofounder, chair and CEO of Bond Biosciences based in the Kansas City area; co ...Cory Berkland. The Berkland Lab investigates pharmaceuticals and biomaterials. They aim to understand the transport of pharmaceuticals as a function of physical and …Abstract. Lung surfactant is crucial for optimal pulmonary function throughout life. An absence or deficiency of surfactant can affect the surfactant pool leading to respiratory distress. Even if the coupling between surfactant dysfunction and the underlying disease is not always well understood, using exogenous surfactants as replacement is ...The long-term objective of this application is to deliver a unique biomaterial that can easily be molded into place by a surgeon, and will resorb as it induces rapid tissue regeneration. Toward this o...Cory Berkland, PhD. WIZARD FEATURES. © 2023 DeKosky Lab.Jun Yang, Sheng-Xue Xie, Yiling Huang, Min Ling, Jihong Liu, Yali Ran, Yanlin Wang, J Brantley Thrasher, Cory Berkland, Benyi Li. Prostate-targeted biodegradable nanoparticles loaded with androgen receptor silencing constructs eradicate xenograft tumors in mice. Nanomedicine 2012, 7 (9) , 1297-1309.How it works: Cory Berkland, Ph.D., professor at the University of Kansas, is a serial entrepreneur, co-founding Orbis Biosciences, Savara Pharmaceuticals and Orion Biosciences, as well as co-developing several technologies with industry partners. In late 2012, IAMI invested in novel polymer technology discovered by Dr. Berkland with the intent ...Lymphatic trafficking kinetics and near-infrared imaging using star polymer architectures with controlled anionic character Taryn R. Bagby1, Shuang Cai1, Shaofeng Duan1, Qiuhong Yang1, Sharadvi Thati1, Cory Berkland1, Daniel J. Aires2, and M. Laird Forrest1,* 1 Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 2 Division of Dermatology, Dept. of Internal Medicine ...Cory Berkland Mario Rivera Kate ESHELMAN Jian QIAN Nashwa EL-GENDY Original Assignee The University Of Kansas Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) 2014-10-10 Filing date 2015-10-08 Publication ...Alhakamy NA, Berkland CJ. Glatiramer Acetate (Copaxone®) is a Promising Gene Delivery Vector. Molecular Pharmaceutics. PMID 30865465 DOI: 10.1021/acs.molpharmaceut.8b01282 : 0.4: 2018: Xie SX, Baoum A, Alhakamy NA, Berkland CJ. Calcium enhances gene expression when using low molecular weight poly-L-lysine delivery vehicles.Author: Susan MacNally Created Date: 08/20/2021 11:09:00 Title: Conflict management plan for Cory Berkland (L0013204-5).DOC Subject: L0013204 / 5 Last modified byAug 3, 2015 · Abstract. Antibiotic multi-resistant pneumonia is a risk associated with long term mechanical ventilation. Vancomycin is commonly prescribed for methicillin-resistant staphylococcus aureus infections; however, current formulations of vancomycin are only given intravenously. High doses of vancomycin have been associated with severe renal toxicity. Nabil A Alhakamy 1 , David T Curiel 2 , Cory J Berkland 3 Affiliations 1 Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia; ... University of Kansas, Lawrence, KS 66047, USA. Electronic address: [email protected]. PMID: 33781953 DOI: 10.1016/j.drudis.2021.03.021 AbstractCory Berkland. Corresponding Author. E-mail address: [email protected]. Department of Chemical & Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047.TY - JOUR. T1 - Monodisperse liquid-filled biodegradable microcapsules. AU - Berkland, Cory. AU - Pollauf, Emily. AU - Varde, Neel. AU - Pack, Daniel W.Qingting Hu, 1 Megan Myers, 1 Wei Fang, 1 Min Yao, 1 Gage Brummer, 1 Justin Hawj, 1 Curtis Smart, 1 Cory Berkland, 2 and Nikki Cheng 1, 3, * Qingting Hu 1 Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USAKhia Preston Director Of Operations at The UPS Store - #3263, 2473, 3354, 3723, 1152, 3443, 075416‏/05‏/2014 ... The principal investigator from the University of Kansas for the project is Cory Berkland, KU professor of chemical and petroleum engineering ...Pressnall MM, Huayamares SG, Berkland CJ. Immunostimulant Complexed with Polylysine Limits Transport and Maintains Immune Cell Activation. Journal of Pharmaceutical Sciences. PMID 32565351 DOI: 10.1016/j.xphs.2020.06.009 : 0.56: 2020: Griffin JD, Song JY, Sestak JO, DeKosky BJ, Berkland CJ. Linking autoantigen properties to mechanisms of immunity.Title: FLT3-specific curcumin micelles enhance activity of curcumin on FLT3-ITD overexpressing MV4-11 leukemic cells: Authors: Singkome Tima Siriporn OkonogiLymphatic trafficking kinetics and near-infrared imaging using star polymer architectures with controlled anionic character Taryn R. Bagby1, Shuang Cai1, Shaofeng Duan1, Qiuhong Yang1, Sharadvi Thati1, Cory Berkland1, Daniel J. Aires2, and M. Laird Forrest1,* 1 Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 2 Division of Dermatology, Dept. of Internal Medicine ...Dr. Cory Berkland Solon E. Summerfield Distinguished Professor School of Engineering, School of Pharmacy Chemical and Petroleum Engineering, Pharmaceutical Chemistry RESEARCH INTERESTS Antigen-specific immunotherapies, sequestering cells to combat autoimmunity, autoimmunity and tolerance reintroduction, targeted drug delivery, and gene delivery.Cory Berkland, Ph.D.-Solon E. Summerfield Distinguished Professor-Chemical and Petroleum Engineering-Pharmaceutical Chemistry; View full profile . Cory Berkland [email protected] Department of Chemical and Petroleum Engineering, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047.Nathan H. Dormer, Jennifer Nelson-Brantley, Hinrich Staecker, Cory J. Berkland, Evaluation of a transtympanic delivery system in Mus musculus for extended release steroids, European Journal of Pharmaceutical Sciences, 10.1016/j.ejps.2018.01.020, 126, (3-10), (2019).Cory Berkland. Solon E. Summerfield Distinguished Professor. PHARMACEUTICAL CHEMISTRY. Contact Info. 785-864-1455. Multidisciplinary Research Building, Room …Name: CORY BERKLAND Phone: (785) 864-1455 Email: [email protected]. Business Contact. Name: CORY BERKLAND Phone: (785) 764-0125 Email: [email protected]. Research Institution. N/A . Abstract. PROJECT SUMMARY/ABSTRACT Hereditary Hemochromatosis (HH) is one of the most common genetic disorders in the United …Cory Berkland. Professor Cory Berkland's lab continues to bridge research in Pharmaceutical Chemistry, Chemical Engineering, and Bioengineering at KU. The lab recently completed a research collaboration with Orion BioScience sponsored by the Juvenile Diabetes Research Foundation aiming to prevent the progression of Type 1 Diabetes using ...Min Huang 1 and Cory Berkland 1, 2, * Author ... Peek LJ, Coop T, Berkland C. Polyelectrolyte complexes stabilize and controllably release vascular endothelial growth ...That effort led to an NIH grant with Cory Berkland, Ph.D., of the University of Kansas, as principal investigator. Flash forward to present day and Detamore is a principal investigator of this current NIH project. Berkland, Dr. Brian Andrews, a surgeon who specializes in head and neck surgery at the University of Iowa Hospitals and Clinics, and ...Jun 6, 2016 · 1. INTRODUCTION. Hyaluronic acid (HA) is a linear biopolymer component of multiple approved products and exhibits versatility for drug delivery, since it is available in a wide range of molecular weights and offers multiple sites for chemical modification. 1–6 In the human body, HA is prevalent in cartilage, skin, and synovial fluid and is typically present as a very high molecular weight ... El-Gendy Nashwa, Huang Shan, Selvam Parthiban, Soni Pravin, Berkland Cory. Development of Budesonide NanoCluster Dry Powder Aerosols: Formulation and Stability. Journal of Pharmaceutical Sciences. 2012; 101 (9):3445-3455. [Google Scholar] 38. El-Gendy Nashwa, Huang Shan, Selvam Parthiban, Soni Pravin, Berkland Cory. ...By Akihisa Nonoyama, Ph.D., Nathan Dormer, Ph.D., and Cory Berkland, Ph.D., Adare Pharma Solutions Quetiapine is an antipsychotic drug used for the treatment of schizophrenia, bipolar disorder and depression and is currently marketed as a QD tablet. An alternate presentation of the drug in the form of controlled release microspheres would ...Cory Berkland. 2007, Journal of Pharmaceutical Sciences. Novel macromolecular therapeutics such as peptides, proteins, and DNA are advancing rapidly toward the clinic. Because of typically low oral bioavailability, macromolecule delivery requires invasive methods such as frequently repeated injections. Parenteral depots including biodegradable ...Supang Khondee, Tatyana Yakovleva, Cory Berkland. First published: 04 August 2010. https://doi.org/10.1002/app.32460. Citations: 2. Read the full text. PDF. …Name: CORY BERKLAND Phone: (785) 864-1455 Email: [email protected]. Business Contact. Name: CORY BERKLAND Phone: (785) 764-0125 Email: [email protected]. Research Institution. N/A . Abstract. PROJECT SUMMARY/ABSTRACT Hereditary Hemochromatosis (HH) is one of the most common genetic disorders in the United States affectingCory Berkland Laird Forrest Michael Hageman Jeff Krise Sue Lunte Russ Middaugh Christian Schöneich Teruna Siahaan John Stobaugh Thomas Tolbert David Volkin Michael Wang Undergraduate Research Program ...How it works: Cory Berkland, Ph.D., professor at the University of Kansas, is a serial entrepreneur, co-founding Orbis Biosciences, Savara Pharmaceuticals and Orion Biosciences, as well as co-developing several technologies with industry partners. In late 2012, IAMI invested in novel polymer technology discovered by Dr. Berkland with the intent ...Cory Berkland, PhD He will be starting as a Professor in the Biomedical Engineering Department and the Chemistry Department at Washington University, Fall 2023. He received MS and PhD degrees from the Department of Chemical and Biomolecular Engineering at the University of Illinois in Urbana-Champaign and a BS degree in Chemical Engineering ...1. Introduction to hyaluronic acid. Hyaluronic acid (HA), also named hyaluronan, is a high molecular weight (10 5 –10 7 Da) naturally occurring biodegradable polymer. HA is an unbranched non-sulfated glycosaminoglycan (GAG) composed of repeating disaccharides (β-1,4-D-glucuronic acid (known as uronic acid) and β-1,3-N-acetyl-D-glucosamide) …Qingting Hu, 1 Megan Myers, 1 Wei Fang, 1 Min Yao, 1 Gage Brummer, 1 Justin Hawj, 1 Curtis Smart, 1 Cory Berkland, 2 and Nikki Cheng 1, 3, * Qingting Hu 1 Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USAliquid droplets (Berkland et al. 2001). A schematic diagram of the PPF nozzle is illustrated in Figure 1. The PLGA/ analyte solution is forced via a syringe pump (New Era Pump Systems, Wantagh, NY) through a 22-gauge hypo-dermic needle at flow rates from 1–10 mL h 1. An annular immiscible stream of water containing a mass concentra-03‏/04‏/2023 ... ... Cory J Berkland. Affiliations. 1 Bioengineering Program, The University of Kansas, Lawrence, Kansas 66045, United States. 2 HylaPharm ...Todd Berkland Work Experience and Education. According to ZoomInfo records, Todd Berkland`s professional experience began in 2000. Since then Todd has changed 4 companies and 3 roles. Currently, Todd Berkland works as a Vice President, Business Development & Acquisitions at Wrench Group.BERKLAND CORY. Author information. Affiliations. All authors. 1. KIM KYEKYOON Patent: Reexamination Certificate Second Reexamination - United States Application: US20030624029 on 21 Jul 2003 Publication: 21 Jul 2003 PAT: US7368130 . Patent. Share this article ...Todd Berkland Work Experience and Education. According to ZoomInfo records, Todd Berkland`s professional experience began in 2000. Since then Todd has changed 4 companies and 3 roles. Currently, Todd Berkland works as a Vice President, Business Development & Acquisitions at Wrench Group.Cory Berkland. Solon E. Summerfield Distinguished Professor. Department of Pharmaceutical Chemistry. Contact Info. [email protected]. 785-864-1455. …Modeling release of small molecules from degradable microspheres is important to the design of controlled-release drug delivery systems. Release of small molecules from poly(d,l-lactide-co-glycolide) (PLG) particles is often controlled by diffusion of the drug through the polymer and by polymer degradation.Cory Berkland Professor Berkland has garnered international attention for his seminal research on colloids and materials applied to science. His award is in recognition of a series of closely related research contributions that fundamentally define and apply the phenomena of nanoparticle assembly as a means to emulate naturally occurring ...Nabil Alhakamy • Cory Berkland • Jin Chen • Dana Brantley-Sieders • Nikki Cheng Received: 4 December 2014/Accepted: 24 February 2015/Published online: 6 March 2015 Springer Science+Business Media New York 2015 Abstract Luminal A and B breast cancers are the most prevalent forms of breast cancer diagnosed in women.Shara Thati, 1 Christopher Kuehl, 1 Brittany Hartwell, 2 Joshua Sestak, 1 Teruna Siahaan, 1 Laird Forrest, 1 and Cory Berkland 1, 3, * Shara Thati 1 Department of Pharmaceutical Chemistry, University of Kansas, 2030 Becker Dr, Lawrence, KS 66047Cory Berkland, Ph.D. Abstract Basic principles have emerged for oral and intravenous drug design, but fewer efforts have ... Berkland is a co-founder of Orbis Biosciences (purchased by Adare Pharmaceuticals), Savara Pharmaceuticals (NASDAQ: SVRA), Bond Biosciences, and Orion BioScience. Title: Microsoft Word - Cory Berkland Seminar Announcement ...Cory Berkland Mario Rivera Kate ESHELMAN Jian QIAN Nashwa EL-GENDY Original , Cory Berkland. Department of Chemical and Petroleum Engineering, University of Kan, Cory Berkland Professor Biomedical Engineering [email protected] Google S, Min Huang 1 and Cory Berkland 1, 2, * Author ... Peek LJ, Coop T, Berkland C. Polyelec, Cory Berkland, Ph.D. Date. Friday, January 29, 2021 - 12:00pm. Location. University of Houston. A, Jian Qian, Bradley P. Sullivan, Samuel J. Peterson, and Cory, That effort led to an NIH grant with Cory Berkland, Ph.D., of the University of Kansas, as principal, Dec 29, 2017 · J. Daniel Griffin, Martin A. Leon, , Course Search. Search class sections | Online courses. Library Searc, Search 4 grants from Maria Flynn Search 22 grants from Cory Berkland , Cory Berkland. Professor Cory Berkland's lab continues to br, Lymphatic trafficking kinetics and near-infrared imaging using , Patent number: 11390795. Abstract: The invention is directed to , J. Daniel Griffin, Martin A. Leon, Jean R. Salash, Micha, Introduction. Hollow particles, also referred to as caps, Patent number: 10398649. Abstract: Particles for delivery of a, Berkland, Cory J. Publisher. Nature Publishing Group, Qingting Hu, 1 Megan Myers, 1 Wei Fang, 1 Min Yao, 1 Gage Brummer, 1.